{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:27:31Z","timestamp":1790389651851,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":3334,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s13311-014-0285-y","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T07:44:32Z","timestamp":1403163872000},"page":"651-664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["PARP Inhibition Delays Progression of Mitochondrial Encephalopathy in Mice"],"prefix":"10.1016","volume":"11","author":[{"given":"Roberta","family":"Felici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Cavone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lapucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Guasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Bani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Chiarugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-014-0285-y_bib1","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1126\/science.283.5407.1482","article-title":"Mitochondrial diseases in man and mouse","volume":"283","author":"Wallace","year":"1999","journal-title":"Science"},{"key":"10.1007\/s13311-014-0285-y_bib2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pathol.4.110807.092314","article-title":"Mitochondrial energetics and therapeutics","volume":"5","author":"Wallace","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"10.1007\/s13311-014-0285-y_bib3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/0883073813481622","article-title":"Mitochondrial disease: a challenge for the caregiver, the family, and society","volume":"28","author":"Sofou","year":"2013","journal-title":"J Child Neurol"},{"key":"10.1007\/s13311-014-0285-y_bib4","article-title":"Treatment for mitochondrial disorders","volume":"4","author":"Pfeffer","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1007\/s13311-014-0285-y_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrd4023","article-title":"Pharmacological approaches to restore mitochondrial function","volume":"12","author":"Andreux","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1007\/s13311-014-0285-y_bib6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10545-009-9005-x","article-title":"Mouse models for nuclear DNA-encoded mitochondrial complex I deficiency","volume":"34","author":"Koene","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1007\/s13311-014-0285-y_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ddrr.107","article-title":"Complex I disorders: causes, mechanisms, and development of treatment strategies at the cellular level","volume":"16","author":"Valsecchi","year":"2010","journal-title":"Dev Disabil Res Rev"},{"key":"10.1007\/s13311-014-0285-y_bib8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cmet.2008.02.004","article-title":"Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy","volume":"7","author":"Kruse","year":"2008","journal-title":"Cell Metab"},{"key":"10.1007\/s13311-014-0285-y_bib9","doi-asserted-by":"crossref","first-page":"10996","DOI":"10.1073\/pnas.1006214107","article-title":"Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome","volume":"107","author":"Quintana","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-014-0285-y_bib10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrc3340","article-title":"The NAD metabolome \u2013 a key determinant of cancer cell biology","volume":"12","author":"Chiarugi","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1007\/s13311-014-0285-y_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1101\/sqb.2012.76.010439","article-title":"NAD+ as a signaling molecule modulating metabolism","volume":"76","author":"Canto","year":"2011","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1007\/s13311-014-0285-y_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1083\/jcb.201207019","article-title":"Exploring the therapeutic space around NAD+","volume":"199","author":"Houtkooper","year":"2012","journal-title":"J Cell Biol"},{"key":"10.1007\/s13311-014-0285-y_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj3420249","article-title":"Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions","volume":"342","author":"D'Amours","year":"1999","journal-title":"Biochem J"},{"key":"10.1007\/s13311-014-0285-y_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrm3376","article-title":"New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs","volume":"13","author":"Gibson","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1007\/s13311-014-0285-y_bib15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ceb.2008.03.006","article-title":"Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation","volume":"20","author":"Kraus","year":"2008","journal-title":"Curr Opin Cell Biol"},{"key":"10.1007\/s13311-014-0285-y_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0092-8674(03)00433-1","article-title":"PARP goes transcription","volume":"113","author":"Kraus","year":"2003","journal-title":"Cell"},{"key":"10.1007\/s13311-014-0285-y_bib17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tips.2010.02.003","article-title":"Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases","volume":"31","author":"Imai","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"10.1007\/s13311-014-0285-y_bib18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MOL.0b013e328328d0a4","article-title":"PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure","volume":"20","author":"Canto","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"10.1007\/s13311-014-0285-y_bib19","doi-asserted-by":"crossref","first-page":"20408","DOI":"10.1074\/jbc.M109.016469","article-title":"Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters","volume":"284","author":"Zhang","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-014-0285-y_bib20","doi-asserted-by":"crossref","first-page":"43121","DOI":"10.1074\/jbc.M506162200","article-title":"Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity","volume":"280","author":"Pillai","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-014-0285-y_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cmet.2011.03.004","article-title":"PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation","volume":"13","author":"Bai","year":"2011","journal-title":"Cell Metab"},{"key":"10.1007\/s13311-014-0285-y_bib22","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1124\/mol.111.073916","article-title":"Pharmacological effects of exogenous NAD on mitochondrial bioenergetics, DNA repair, and apoptosis","volume":"80","author":"Pittelli","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1007\/s13311-014-0285-y_bib23","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","article-title":"The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity","volume":"15","author":"Canto","year":"2012","journal-title":"Cell Metab"},{"key":"10.1007\/s13311-014-0285-y_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrd1718","article-title":"Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors","volume":"4","author":"Jagtap","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1007\/s13311-014-0285-y_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrc2812","article-title":"PARP inhibition: PARP1 and beyond","volume":"10","author":"Rouleau","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1007\/s13311-014-0285-y_bib26","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1517\/13543770903215883","article-title":"Poly(ADP-ribose) polymerase inhibition in cancer therapy: are we close to maturity?","volume":"19","author":"Papeo","year":"2009","journal-title":"Expert Opin Ther Pat"},{"key":"10.1007\/s13311-014-0285-y_bib27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1254\/jjp.27.117","article-title":"Effects of central depressants on rota-rod and traction performances in mice","volume":"27","author":"Kuribara","year":"1977","journal-title":"Jpn J Pharmacol"},{"key":"10.1007\/s13311-014-0285-y_bib28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/icb.2013.85","article-title":"Nicotinamide phosphoribosyltransferase (NAMPT) activity is essential for survival of resting lymphocytes","volume":"92","author":"Pittelli","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"10.1007\/s13311-014-0285-y_bib29","doi-asserted-by":"crossref","first-page":"e76938","DOI":"10.1371\/journal.pone.0076938","article-title":"Insight into molecular and functional properties of NMNAT3 reveals new hints of NAD homeostasis within human mitochondria","volume":"8","author":"Felici","year":"2013","journal-title":"PLoS One"},{"key":"10.1007\/s13311-014-0285-y_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.nbd.2009.07.019","article-title":"Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo","volume":"36","author":"Faraco","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-014-0285-y_bib31","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1124\/mol.106.027912","article-title":"Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic Acid specifically alters gene expression and reduces ischemic injury in the mouse brain","volume":"70","author":"Faraco","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1007\/s13311-014-0285-y_bib32","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.bbadis.2008.10.015","article-title":"A critical approach to the therapy of mitochondrial respiratory chain and oxidative phosphorylation diseases","volume":"1792","author":"Dimauro","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1007\/s13311-014-0285-y_bib33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0165-6147(00)01902-7","article-title":"PARP-1: killer or conspirator? The suicide hypothesis revisited","volume":"23","author":"Chiarugi","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1007\/s13311-014-0285-y_bib34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nbt.2121","article-title":"Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors","volume":"30","author":"Wahlberg","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1007\/s13311-014-0285-y_bib35","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1152\/physrev.00025.2007","article-title":"Transcriptional paradigms in mammalian mitochondrial biogenesis and function","volume":"88","author":"Scarpulla","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1007\/s13311-014-0285-y_bib36","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/cmdc.200800010","article-title":"On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives","volume":"3","author":"Pellicciari","year":"2008","journal-title":"Chem Med Chem"},{"key":"10.1007\/s13311-014-0285-y_bib37","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.cmet.2011.03.013","article-title":"PARP-2 regulates SIRT1 expression and whole-body energy expenditure","volume":"13","author":"Bai","year":"2011","journal-title":"Cell Metab"},{"key":"10.1007\/s13311-014-0285-y_bib38","doi-asserted-by":"crossref","first-page":"10374","DOI":"10.1074\/jbc.M513387200","article-title":"Dysfunctions of cellular oxidative metabolism in patients with mutations in the NDUFS1 and NDUFS4 genes of complex I","volume":"281","author":"Iuso","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-014-0285-y_bib39","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1172\/JCI62923","article-title":"Fatal breathing dysfunction in a mouse model of Leigh syndrome","volume":"122","author":"Quintana","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1007\/s13311-014-0285-y_bib40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.expneurol.2009.03.020","article-title":"Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos","volume":"218","author":"Wang","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-014-0285-y_bib41","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1471-4159.2003.01684.x","article-title":"Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders","volume":"85","author":"Chiarugi","year":"2003","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-014-0285-y_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/bbrc.2001.5115","article-title":"Poly(ADP-ribosyl)ation of transcription factor Yin Yang 1 under conditions of DNA damage","volume":"285","author":"Oei","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1007\/s13311-014-0285-y_bib43","doi-asserted-by":"crossref","first-page":"8621","DOI":"10.1074\/jbc.M807198200","article-title":"Poly(ADP-ribose) polymerase 1 interacts with nuclear respiratory factor 1 (NRF-1) and plays a role in NRF-1 transcriptional regulation","volume":"284","author":"Hossain","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-014-0285-y_bib44","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1124\/mol.110.070110","article-title":"Poly(ADP-ribose) polymerase-1 is a nuclear epigenetic regulator of mitochondrial DNA repair and transcription","volume":"79","author":"Lapucci","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1007\/s13311-014-0285-y_bib45","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1126\/science.1244360","article-title":"mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome","volume":"342","author":"Johnson","year":"2013","journal-title":"Science"},{"key":"10.1007\/s13311-014-0285-y_bib46","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.cmet.2014.04.001","article-title":"NAD-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease","volume":"19","author":"Cerutti","year":"2014","journal-title":"Cell Metab"},{"key":"10.1007\/s13311-014-0285-y_bib47","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cmet.2014.04.002","article-title":"Pharmacological inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle","volume":"9","author":"Pirinen","year":"2014","journal-title":"Cell Metab"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-014-0285-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-014-0285-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923008899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923008899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-014-0285-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:44:33Z","timestamp":1761806673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923008899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1878747923008899"],"URL":"https:\/\/doi.org\/10.1007\/s13311-014-0285-y","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PARP Inhibition Delays Progression of Mitochondrial Encephalopathy in Mice","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-014-0285-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}